Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health

LONDON, Nov. 13, 2025 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its latest Companies to Watch report, Rediscovering Women’s Health, highlighting seven companies driving innovation across reproductive care, chronic disease and mental health. Drawing on proprietary data, expert analysis and insights into therapeutic impact, financing activity and R&D momentum, the report showcases why these companies are recognized as high-impact innovators.

Despite representing half the global population, women remain underrepresented in clinical research and healthcare investment, with women’s health accounting for just 15% of venture capital and 5% of global healthcare R&D funding. Rediscovering Women’s Health highlights organizations addressing these gaps through inclusive research, novel therapies and a deeper understanding of female-specific conditions such as early menopause, polycystic ovary syndrome (PCOS) and endometriosis, factors that influence broader outcomes like cardiovascular disease and dementia. The report also highlights growing momentum in women’s health R&D.

Anne Lecocq, SVP and GM, R&D, Life Sciences & Healthcare, Clarivate, said: “Women’s health is no longer being defined solely by reproductive care; it’s being reframed through a broader lens that recognizes how biological and social factors shape outcomes across every therapeutic area. This shift marks a pivotal moment for the industry, as data-driven innovation and inclusive research begin to translate into more equitable care and better health outcomes for women worldwide. By spotlighting organizations driving this change, the Companies to Watch report underscores how scientific insight and investment can work together to close persistent gaps and advance women’s health globally.”

Agnès Arbat, MD, Co-Founder and CEO, Oxolife, said: “The next era of women’s health innovation will be defined by science that recognizes women’s unique biology as the foundation for discovery. Across the industry, we’re seeing a long-overdue shift toward inclusive research and smarter, more targeted therapies that can truly transform outcomes for women.”

These companies are pioneering solutions that challenge outdated paradigms and promote equitable care. Clarivate analysts reviewed deal valuations, clinical trials, patents and market approvals to identify seven Companies to Watch in the space:

• Daré Bioscience (USA): focused on accelerating innovation in women’s health by delivering evidence-based solutions that address long-standing unmet needs across contraception, sexual and vaginal health, pelvic pain, fertility, infectious disease and menopause.
• Freya™ Biosciences (Denmark/USA): leveraging its DYSCOVER™ multi-omics platform to develop microbial immunotherapies, including investigational vaginal therapy FB301, targeting chronic inflammation in female reproductive diseases and improving IVF outcomes.
• Gesynta Pharma (Sweden): developing treatments for chronic inflammation and pain, including lead candidate vipoglanstat, a non-hormonal, non-opioid, disease-modifying therapy for endometriosis.
• Granata Bio Corporation (USA): dedicated to advancing reproductive health by developing fertility treatments that expand options, improve access and affordability and drive innovation.
• Hope Medicine (Mainland China): developing therapies for endocrine, cardiovascular, and metabolic diseases, with a special focus on women’s health, including lead asset HMI-115 targeting prolactin signaling to treat endometriosis, alopecia and related conditions.
• Oxolife (Spain): developing OXO-001 to improve fertility and live birth rates by enhancing embryo implantation, restoring ovulation, improving metabolic health and reducing pregnancy loss.
• Reunion Neurosciences (USA): developing psychedelic-inspired therapies, with lead candidate RE104 targeting postpartum depression and adjustment disorders to provide fast-acting benefits with limited psychoactive effects.

Greater awareness, stronger regulatory frameworks supporting sexual health equity and increasing financial investment are accelerating progress in women’s health. These developments create meaningful opportunities for the pharmaceutical industry to help close long-standing gaps and address unmet health needs for women worldwide.

Learn more about emerging innovations and the seven companies shaping the future of women’s health in the full Companies to Watch report, Rediscovering Women’s Health, here.

Methodology for the Companies to Watch Report
Clarivate analysts employed a rigorous, multidimensional framework to identify the emerging innovators featured in this Companies to Watch report. Each company was assessed for its ability to address critical scientific, clinical and business challenges within the women’s health space. Key considerations included demonstrated proof of concept, achievement of developmental milestones and positioning within the clinical trial landscape. The evaluation also factored in the strength of collaborations with leading academic and research institutions, the potential to address significant unmet medical needs and the overall burden of disease targeted by each therapy. Financial health was a further determinant, with analysts examining capital raised, investor partnerships, projected runway and prospects for future growth through fundraising or strategic alliances. Finally, each company’s intellectual property estate was analyzed to understand the strength and breadth of its innovation pipeline. The assessment was underpinned by insights from Clarivate’s trusted proprietary data sources, including Cortellis Competitive Intelligence, Cortellis Deals Intelligence, Cortellis Regulatory Intelligence, Cortellis Clinical Trials Intelligence and BioWorld, ensuring a holistic view of the companies poised to shape the future of precision oncology.

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare.  For more information, please visit clarivate.com.

Media Contact:
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
newsroom@clarivate.com

CANBERRA, Australia, Nov. 13, 2025 /PRNewswire/ — Seeing Machines Limited, the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety announces the launch of its enhanced distraction detection feature, known as “attention sharing”, in its leading Aftermarket safety solution, Guardian Generation 3. This feature is the first of its kind available to fleets worldwide, capturing subtle distraction events that other driver safety systems often miss.

Attention sharing marks a major leap forward in driver distraction detection, measuring not just where a driver looks, but precisely how much time they spend with their eyes off the road. By accurately tracking cumulative glance time away from the driving task, for example any number of quick glances to a phone or other in-cabin systems, attention sharing detection offers an unprecedented window into distraction risk, enabling intervention before safety is compromised. 

“Distraction isn’t always obvious,” said Paul McGlone, CEO of Seeing Machines. “While many systems can detect a driver looking down for a few seconds, this new feature goes further – it identifies the repeated, split-second glances that, when added up, can be just as dangerous. This is a world-first for commercial fleets and a game-changer for road safety, exactly what we at Seeing Machines have set out to achieve.” 

The launch of attention sharing detection comes at a critical time for the transport industry. Global studies show that short, frequent glances away from the road can significantly increase crash risk (Klauer et al., 2006; Olson et al., 2009) and occur more frequently than previously thought.^{[1], [2]} The “attention sharing” feature is now available on all new Guardian Gen 3 systems and is being deployed over-the-air to Guardian Gen 3 systems already installed in trucks and buses.

Watch the video here.

Unlike systems that rely solely on head position or single, prolonged glances, Guardian continuously tracks eye gaze direction in real time, delivering unmatched accuracy. This ensures drivers are alerted only when genuine risk is detected, reducing irritation and fatigue from unnecessary alarms. 

Seeing Machines’ technology is already protecting millions of drivers across the globe, preventing fatigue- and distraction-related incidents daily. With attention sharing detection, commercial fleets using Guardian Generation 3 have an automotive-grade safety technology, scientifically designed and proven to significantly reduce risk and save lives.  

~ENDS~

About Seeing Machines (AIM: SEE), a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines’ technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable “driver state” measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical. www.seeingmachines.com

HANOVER, Germany, Nov. 13, 2025 /PRNewswire/ — At Agritechnica 2025, the world’s leading trade fair for agricultural machinery, XAG unveiled its latest innovations, introducing the P150 Max Agricultural Drone and the R Series Agricultural Rover. The new drone offers high payload capacity and full autonomy, while the rover is designed for precision crop protection in orchards and greenhouses. Together, they demonstrate how XAG integrates robotics and intelligence to make field operations smarter and more productive.

Held every two years in Hanover, Germany, Agritechnica drew around 500,000 visitors and over 2,700 exhibitors from 53 countries. As a global leader in agricultural robotics, XAG presented its full suite of smart farming technologies, including multifunction drones, lightweight rovers, autopilot consoles for tractors and transplanters, smart fertigation systems and IoT sensors. The exhibits highlighted how automation and AI-driven solutions are helping farmers enhance efficiency, optimize resources, and narrow the yield gap.

XAG P150 Max Agricultural Drone: High-Payload, Autonomous Efficiency
The XAG P150 Max Agricultural Drone delivers next-level performance, intelligence, and stability to take on a wide range of field operations. Swapping task systems for precision spraying, spreading, field mapping, and logistics, it enables farmers to complete tasks with greater accuracy and efficiency.

With an 80‑kilogram payload capacity and a maximum flight speed of 20 meters per second, the P150 Max handles demanding tasks across challenging terrains. Its RevoSpray 5 System, featuring an 80‑liter smart liquid tank and dual centrifugal nozzles, applies up to 32 liters per minute. When configured with the four‑nozzle upgrade kit, the flow rate increases to 46 liters per minute, enabling effective spraying even in orchards with dense canopies. Adjustable droplet sizes ranging from 60 to 500 microns allow precise application across different crops.

For spreading applications such as direct seeding, fertilizing, or powder scattering, the RevoCast 5 System delivers up to 300 kilograms per minute from a 115‑liter smart granule container. Its vertical waving broadcast mechanism improves wind resistance and ensures uniform coverage.

The drone is also equipped with a built‑in RealTerra Field Mapping System, supporting autonomous survey missions covering up to 20 hectares per flight. High‑definition images are processed instantly into detailed field maps, while onboard AI automatically identifies obstacles and field structures to enhance operational safety.

Switching to the RevoSling Module transforms the P150 Max into an aerial transport platform capable of carrying up to 80 kilograms of farm inputs, produce, or other cargo across rough or hard-to-reach terrain, streamlining logistics between plots.

At its core, the SuperX 5 Ultra Intelligent Control System enables fully autonomous flight with centimeter‑level precision. Supported by 4D Imaging Radar and a wide‑angle FPV camera, the drone detects and avoids obstacles such as irrigation pivots, power poles, and overhead lines, maintaining safe and stable performance even in complex environments.

Operators can plan and manage missions via the XAG One App on a smartphone or the SRC 5 Remote Controller, which automatically generates optimal routes based on field shape and terrain. High-precision positioning is maintained by the XRTK 7 Mobile Station, even in remote areas with low signal or without internet access. Powered by the Smart SuperCharge Battery, the P150 Max can recharge in as little as seven minutes using the Parallel Charging Kit, minimizing downtime between flights.

Built on 18 years of research and field experience, the P150 Max delivers upgraded structural design, intelligent control, and enhanced terrain adaptability, providing consistent, high-efficiency performance in real-world farming environments.

XAG R Series Agricultural Rover: Smart Co-Pilot for Specialty Crops

The all-new XAG R Series Agricultural Rover brings intelligent navigation and smart control to ground operations, from plant protection to farm material delivery. Compact and fully electric, the rovers can access terrains where traditional tractors struggle, from dense orchards to narrow vineyard and greenhouse rows.

The R Series includes two models tailored to different farming needs. The R100 Agricultural Rover, with a 120-liter tank, four-wheel drive, and two JetSprayers, offers precise coverage for closely spaced crops such as greenhouse vegetables. The R200 Agricultural Rover, equipped with a 240-liter tank, six-wheel drive, and four JetSprayers, delivers higher capacity for orchards and vineyards with wider spacing.

Both models share XAG’s precision engineering, built on an all-aluminum chassis with a suspended portal axle that maintains balance and traction on uneven terrain. High-speed centrifugal JetSprayers produce 60–200 micron droplets, achieving uniform coverage while reducing chemical and water use.

Farmers can operate the rover remotely using the SRC 5 Smart Remote Controller that features a responsive touchscreen, dual-joystick design, wide-angle FPV live view, and XLink connectivity. This keeps operators safely away from chemicals, protecting their health.

The onboard control system supports handy functions such as Cruise Mode, Path Tracking, and Repeat Mode to simplify daily tasks. With built-in AI safety assistance and RealTerra onboard mapping, the rover analyzes its surroundings, detects obstacles, and adjusts routes in real time to ensure safe and accurate navigation.

For farmers facing labor shortages or rising workloads, the R Series reduces physical strain and transforms repetitive fieldwork into precise and automated tasks. Its expandable platform supports DIY customization for weeding, transport, and other applications, making it a reliable co‑pilot for high-value crop management.

Automated Steering and Smart Irrigation

Complementing its agricultural drone and rover lineup, XAG also showcased the APC2 Series AutoPilot Console and Smart Fertigation System at Agritechnica, highlighting their role as key components of a fully connected smart farm ecosystem.

Launched this year, the APC2 Flex AutoPilot Console brings automated steering to small-and-medium tractors. It enables centimeter-level accuracy in field navigation with minimal effort, reducing fuel consumption and operator fatigue. The console installs in as little as 20 minutes without replacing the steering wheel and is compatible with most tractor and machinery brands. It integrates seamlessly through the XAG AutoPilot App to support precise and consistent operation across different field types and terrains.

The Smart Fertigation System and IoT products extend automation to irrigation and nutrient management while offering a lower entry barrier for farmers. Featuring smart electric valves and fertilizer injectors, the system delivers water and nutrients directly to plant roots with precision. Farmers can plan, manage, and monitor operations remotely through an app at any time. Supported by the XAG Local Server and Wireless Relay, the system maintains stable connectivity and data security even in areas without network coverage.

The launch of the P150 Max Agricultural Drone and R Series Rover marks XAG’s latest step in advancing smart farming. Designed to tackle labor shortages and rising operational costs, these new products enable farmers to complete spraying, spreading, and logistics tasks with precision, efficiency, and minimal manual effort, setting a practical benchmark for sustainable, high-yield agriculture.

CHIANG MAI, Thailand, Nov. 13, 2025 /PRNewswire/ — A major step forward in regional collaboration for cancer care was announced today with the launch of Project ACTIVE 2.0 (Advancing Cervical Cancer Treatment & Patient Recovery Across Southeast Asia), a multi-country initiative that aims to strengthen radiation oncology services and improve outcomes for cervical cancer across Southeast Asia.

This effort is backed by the German Federal Ministry of Economic Cooperation and Development – BMZ, DEG Impulse, the Embassy of the Federal Republic of Germany in Bangkok, Elekta, and the Federation of Asian Organizations for Radiation Oncology (FARO). The program will support clinical capacity-building and knowledge exchange in Thailand, Indonesia, Malaysia, Vietnam, Laos, and Cambodia, countries where cervical cancer remains a leading cause of cancer-related deaths among women.

“ACTIVE 2.0 goes beyond healthcare initiative – it is a regional platform for sustainable development and technical collaboration,” said Professor Imjai Chitapanarux, President of Federation of Asian Organizations for Radiation Oncology (FARO). “We are directly addressing a critical public health challenge by elevating treatment standards and expanding access to advanced radiotherapy.”

The initiative was mooted in response to alarming statistics: In 2022, Southeast Asia recorded 69,833 new cervical cancer cases with over 38,000 deaths^[1]. Despite progress in screening and HPV vaccination, countries like Thailand continue to face significant disease burden, particularly in underserved communities.

“This project underscores Germany’s ongoing dedication to fostering sustainable healthcare partnerships in Thailand and beyond,” added Mr. Sebastian-Justus Schmidt, Honorary Consul of the Federal Republic of Germany in Chiang Mai, Thailand. “By bridging international expertise to Southeast Asia, Project ACTIVE 2.0 is laying the groundwork for stronger oncology services that benefit communities across Southeast Asia.”

“Project ACTIVE 2.0 is designed to reinforce the clinical foundations of radiotherapy in the region,” said Mr. Yohei Watanabe, Vice Director of Project ACTIVE 2.0. “In collaboration with FARO, we aim to equip healthcare professionals with global best practices to ensure every patient receives optimal care.”

International medical experts, including radiation oncologists from Europe, Japan and India, will provide expertise and guidance to the project countries in collaboration with FARO. In Thailand, training and knowledge exchange activities will be developed in close collaboration with Thai medical institutions.

Project ACTIVE 2.0 represents a scalable model for cross-border healthcare cooperation, aligning with global health priorities and the UN Sustainable Development Goals. It offers a compelling example of how international collaboration can drive impactful changes in public health systems.

About ACTIVE 2.0

This project is a radiation oncology-driven initiative backed by governments, technology partners, and the world’s top clinical experts.  It will assemble and deliver key radiotherapy treatments and technologies to drive a multi-city effort against cervical cancer across Southeast Asia. The project has a three-pronged focus on (1) adaptive external beam radiation, (2) image-guided adaptive brachytherapy (IGABT), followed by (3) personalized electronic patient follow-ups. It will ultimately rely on healthcare professionals to deliver hope to everyone dealing with cervical cancer.

About DEG Impulse

A 100% subsidiary of Deutsche Investitions- und Entwicklungsgesellschaft (DEG) mbH, provides companies with advisory and grant funding and advisory solutions for their investments in developing and emerging countries, thus promoting social and ecological transition in the private sector. DEG, a member of the KfW Bankengruppe (KfW banking group), finances investments of private companies in developing and transition countries. It promotes private business structures to contribute to sustainable economic growth and improved living conditions.

About Elekta

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer.

About the Federation of Asian Organizations for Radiation Oncology (FARO)

FARO is a non-profit and scientific organization that serves as a federation of radiation oncology societies in Asia. FARO aims to foster the development of radiation oncology, raise the basic level of radiotherapy practice, and improve the quality of care for cancer patients throughout the Asian region.

About ASSIST

ASSIST is a pan Asian non-profit organization that has been operating in ASEAN and South Asia for the past 20 years. Some of the key focus areas of ASSIST are “Green Economy”, “Education and Skills development”, “Agriculture”, and “Health”.

For further information, please contact:

Panda Narisara (Ms)
Project Manager, ASSIST
narisara@assistasia.org

Haruji Sugano (Ms)
Project Manager, Elekta
Haruji.Sugano@elekta.com